This brand name is authorized in Poland
The drug BISORATIO ASA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Bisoprolol
UNII UR59KN573L - BISOPROLOL FUMARATE
|
|
Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity. |
|
2
Acetylsalicylic acid
UNII R16CO5Y76E - ASPIRIN
|
|
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07FX04 | Bisoprolol and acetylsalicylic acid | C Cardiovascular system → C07 Beta blocking agents → C07F Beta blocking agents and other antihypertensives → C07FX Beta blocking agents, other combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100275202, 100275219 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
